Insulet Corp

Insulet Corporation, established in 2000, has pioneered innovative medical solutions that simplify the lives of people with diabetes. Through its flagship product, the Omnipod Insulin Management System, Insulet has revolutionised the way insulin is delivered, offering a tubeless and wireless solution that enhances freedom and flexibility for users worldwide. Headquartered in Acton, Massachusetts, Insulet remains committed to advancing healthcare technology and improving the quality of life for individuals managing diabetes.

With a workforce of 3,500 dedicated employees, Insulet's mission is to break down the barriers of conventional diabetic treatment and deliver user-friendly, cutting-edge medical devices. The Omnipod System is a testament to Insulet's commitment to innovation, combining sophisticated technology with user-centric design to offer a seamless diabetes management experience. Insulet continues to expand its reach, making significant strides in the global healthcare market.

Under the leadership of CEO Jim Hollingshead​, Insulet fosters a culture of innovation and collaboration, striving to transform healthcare delivery through continuous product development and strategic partnerships. As a front-runner in wearable technology, Insulet is poised to lead the charge in redefining how medical devices can improve patient outcomes, making diabetes management more accessible and less intrusive.